The AffiAB® Goat anti-NSP13 (SARS-CoV-2) Polyclonal IgG Antibody is a highly specific antibody which binds and neutralizes NSP13, an important protein in SARS-CoV-2. This antibody has been specifically designed to be suitable for use in research applications. It has an affinity of over 99%, making it an ideal choice for scientists seeking an exact and reliable antibody.
The AffiAB® Goat anti-NSP13 (SARS-CoV-2) Polyclonal IgG Antibody is a specialized antibody designed to detect and target the NSP13 protein of the SARS-CoV-2 virus. NSP13, also known as helicase, is an essential enzyme involved in viral replication and is crucial for unwinding the viral RNA during the replication process.
This polyclonal antibody is generated by immunizing goats with purified NSP13 protein or a specific peptide sequence derived from NSP13. The resulting antibody is then purified from goat serum using various purification techniques to ensure high specificity and quality.
The AffiAB® Goat anti-NSP13 (SARS-CoV-2) Polyclonal IgG Antibody is widely used in research and diagnostic applications to study the SARS-CoV-2 virus. It can be utilized in techniques such as Western blotting, immunohistochemistry, immunofluorescence, and ELISA to detect and analyze the expression and localization of NSP13 in infected cells or patient samples.
By specifically targeting NSP13, this antibody allows researchers to investigate the role and function of NSP13 in the viral replication process. Understanding the mechanisms of NSP13 and its interaction with other viral components is crucial for gaining insights into SARS-CoV-2 replication and for the development of potential antiviral strategies.
In summary, the AffiAB® Goat anti-NSP13 (SARS-CoV-2) Polyclonal IgG Antibody is a valuable tool for scientists studying the SARS-CoV-2 virus. Its high specificity and sensitivity make it suitable for various research applications related to virology, immunology, and COVID-19 research.